PDF icon Download PDF
Exp Clin Endocrinol Diabetes 2023; 131(05): 290-298
DOI: 10.1055/a-2045-7787
Article

Fasting Plasma Glucose Levels at the Time of Admission Predict 90-Day Mortality in Patients with Viral Pneumonia. A Prospective Study

Jie Xu
1   Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
,
Jianyu Zhao
2   Department of Laboratory Medicine, Shunyi District Hospital of Beijing, Beijing, China
,
Liyuan Wu
3   Department of Laboratory Medicine, Guangzhou Women and Children's Medical Center, Guangzhou, China
,
Xinxin Lu
4   Department of Laboratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China
› Author Affiliations
Funding This study was supported by the research on the pathogenic diagnosis of acute and severe respiratory infectious diseases in general hospitals (2014ZX10004005) and research on relevant technical specifications and standard systems of biosafety sample banks (SQ2019YFC120021).
› Further Information
Also available ateRef
   Permissions and Reprints
Preview

Abstract

Purpose To determine the effect of fasting plasma glucose (FPG) level at admission affects the 90-day mortality rate in patients with viral pneumonia.

Methods Two hundred fifty viral pneumonia patients were stratified into normal FPG (FPG<7.0 mmol/L), moderately-elevated FPG (FPG=7.0–14.0 mmol/L), and highly-elevated FPG groups (FPG≥14.0 mmol/L) according to the FPG level at the time of admission. The clinical characteristics, etiologies, and prognosis of different groups of patients were compared. Kaplan-Meier survival and Cox regression analyses were used to determine the relationship between the FPG level and 90-day all-cause mortality rate in patients with viral pneumonia.

Results Patients in the moderately- and highly-elevated FPG groups had a higher proportion of severe disease and mortality compared with the normal FPG group (P<0.001). Kaplan-Meier survival analysis showed a significant trend toward higher mortality and increased cumulative risk at 30, 60, and 90 d in patients with an FPG=7.0–14.0 mmol/L and an FPG≥14 mmol/L (χ2=51. 77, P<0.001). Multivariate Cox regression analysis revealed that compared with an FPG<7.0 mmol/L, FPG=7.0 and 14.0 mmol/L (HR: 9.236, 95% CI: 1.106–77.119, P=0.040) and FPG≥14.0 mmol/L (HR: 25.935, 95% CI: 2.586–246.213, P=0.005) were independent risk factors for predicting the 90-day mortality rate in viral pneumonia patients.

Conclusions The higher the FPG level at admission in a patient with viral pneumonia, the higher the risk of all-cause mortality within 90 d.

Key words

viral pneumonia - fasting plasma glucose level - type 2 diabetes - survival analysis


Publication History

Received: 29 November 2022
Received: 17 February 2023

Accepted: 16 February 2023

Article published online:
17 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany